Market revenue in 2023 | USD 8.8 million |
Market revenue in 2030 | USD 12.1 million |
Growth rate | 4.6% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 47.73% in 2023. Horizon Databook has segmented the Thailand in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
Growth of the market in the country can be attributed to the rising prevalence of chronic disorders and the growing need for development of novel technologies for use in disease diagnosis. For instance, according to a United Nations report, cancer, diabetes, cardiovascular diseases, and chronic respiratory diseases cause death of 400,000 people in Thailand every year.
The increasing overall disease burden in the country is anticipated to propel the demand for clinical diagnostics and IVD quality control products. Thailand is one of the major medical device markets in Southeast Asia and is regulated by the Thailand Food and Drug Administration (TFDA) under the Ministry of Public Health (MOPH).
In 2021, Thailand's FDA revised its medical device regulations and aligned them with the regional ASEAN Medical Device Directives (AMDD). Moreover, in June 2022, the Ministry of Public Health, the National Health Security Office (NHSO) of Thailand, hospitals, universities, and NGOs collaborated to tackle hepatitis C in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Thailand in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account